Literature DB >> 30892052

Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.

Marta E Bull1,2, Jennifer L McKernan2, Sheila Styrchak2, Kelli Kraft2, Jane Hitti3, Susan E Cohn4, Kenneth Tapia5, Wenjie Deng6, Sarah Holte5,7, James I Mullins5,6,8,9, Robert W Coombs8,9, Lisa M Frenkel1,2,5,8.   

Abstract

Identifying tissue sources of HIV that rebound following "failure" of antiretroviral therapy (ART) is critical to evaluating cure strategies. To assess the role of the uterine cervix and peripheral blood mononuclear cells (PBMC) as viral reservoirs, nearest-neighbor phylogenetic analyses compared genetic relatedness of tissue sequences during ART suppression to those detected in plasma at viral rebound. Blood and genital tract specimens from a natural history cohort of HIV-infected women were collected over 5 years. HIV DNA sequences extracted from PBMC and cervical biopsies during ART suppression and plasma RNA from rebound (defined as HIV RNA >3 log10 copies/mL) were derived by single-genome amplification. Phylogenetic and nearest-neighbor analyses of HIV env sequences and drug resistance in pol sequences were compared between tissues. Nine instances of plasma viral rebound (median HIV RNA 3.6 log10 c/mL; IQR: 3.1-3.8) were detected in 7 of 57 women. Nearest-neighbor analyses found rebound plasma sequences were closer to uterine cervical sequences in 4/9 (44%), closer to PBMC in 3/9 (33%), and ambiguous in 2/9 (22%) cases. Rebound plasma clades (n = 27) shared identical sequences in seven instances with the cervix versus two with PBMC. Novel drug resistance mutations were detected in 4/9 (44%) rebounds. The observed tendency for greater sharing of identical HIV variants and greater nearest-neighbor association between rebounding plasma and uterine cervical versus PBMC sequences suggests that the uterine cervix may be a relevant HIV reservoir. The cervix, a readily accessible tissue in women that can be repeatedly sampled, could help assess the HIV reservoir when evaluating cure strategies.

Entities:  

Keywords:  HIV reservoirs; HIV-infected women; drug resistance; nearest-neighbor analysis; phylogenetics; viral rebound

Year:  2019        PMID: 30892052      PMCID: PMC6588103          DOI: 10.1089/AID.2018.0211

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  58 in total

1.  A new statistic for detecting genetic differentiation.

Authors:  R R Hudson
Journal:  Genetics       Date:  2000-08       Impact factor: 4.562

2.  Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.

Authors:  G M Ortiz; M Wellons; J Brancato; H T Vo; R L Zinn; D E Clarkson; K Van Loon; S Bonhoeffer; G D Miralles; D Montefiori; J A Bartlett; D F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

3.  HyPhy: hypothesis testing using phylogenies.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost; Spencer V Muse
Journal:  Bioinformatics       Date:  2004-10-27       Impact factor: 6.937

4.  Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.

Authors:  Javier Martinez-Picado; Simon D W Frost; Nuria Izquierdo; K Morales-Lopetegi; Silvia Marfil; Teresa Puig; Cecilia Cabrera; Bonaventura Clotet; Lidia Ruiz
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viral quasi species present before initiation of therapy.

Authors:  H Imamichi; K A Crandall; V Natarajan; M K Jiang; R L Dewar; S Berg; A Gaddam; M Bosche; J A Metcalf; R T Davey ; H C Lane
Journal:  J Infect Dis       Date:  2000-12-08       Impact factor: 5.226

6.  Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection.

Authors:  R Shankarappa; J B Margolick; S J Gange; A G Rodrigo; D Upchurch; H Farzadegan; P Gupta; C R Rinaldo; G H Learn; X He; X L Huang; J I Mullins
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Two-sample tests for comparing intra-individual genetic sequence diversity between populations.

Authors:  Peter B Gilbert; A J Rossini; Raj Shankarappa
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

8.  Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.

Authors:  Mark Dybul; Marybeth Daucher; Mark A Jensen; Claire W Hallahan; Tae-Wook Chun; Michael Belson; Bertha Hidalgo; David C Nickle; Christian Yoder; Julia A Metcalf; Richard T Davey; Linda Ehler; Diane Kress-Rock; Elizabeth Nies-Kraske; Shuying Liu; James I Mullins; Anthony S Fauci
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

9.  Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.

Authors:  Marek Fischer; Beda Joos; Bernard Hirschel; Gabriela Bleiber; Rainer Weber; Huldrych F Günthard
Journal:  J Infect Dis       Date:  2004-11-03       Impact factor: 5.226

10.  HIV RNA in plasma rebounds within days during structured treatment interruptions.

Authors:  Marek Fischer; Roland Hafner; Christine Schneider; Alexandra Trkola; Beda Joos; Helen Joller; Bernard Hirschel; Rainer Weber; Huldrych F Günthard
Journal:  AIDS       Date:  2003-01-24       Impact factor: 4.177

View more
  2 in total

Review 1.  Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection.

Authors:  Chuen-Yen Lau; Matthew A Adan; Frank Maldarelli
Journal:  Viruses       Date:  2021-12-14       Impact factor: 5.048

2.  Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption.

Authors:  Chuen-Yen Lau; Matthew A Adan; Jessica Earhart; Cassie Seamon; Thuy Nguyen; Ariana Savramis; Lindsey Adams; Mary-Elizabeth Zipparo; Erin Madeen; Kristi Huik; Zehava Grossman; Benjamin Chimukangara; Wahyu Nawang Wulan; Corina Millo; Avindra Nath; Bryan R Smith; Ana M Ortega-Villa; Michael Proschan; Bradford J Wood; Dima A Hammoud; Frank Maldarelli
Journal:  Front Med (Lausanne)       Date:  2022-08-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.